MARK MOSS, MD
Pediatric Allergy/Immunology Physician in MADISON, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK MOSS, MD filed 568 Medicare Part D claims in 2023 as a Pediatric Allergy/Immunology Physician in MADISON, Wisconsin, prescribing 48% generic.
- 568
- Part D claims, 2023
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK MOSS, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
568 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
MARK MOSS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARK MOSS, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Wisconsin
How Pediatric Allergy/Immunology Physician compares to other specialties among Wisconsin providers
Pediatric Allergy/Immunology Physician share within Wisconsin
Pediatric Allergy/Immunology Physician is one of the more visible NUCC categories in Wisconsin
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pediatric Allergy/Immunology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pediatric Allergy/Immunology Physician ABMS/AOA estimate
Est. board-certified rate (Pediatric Allergy/Immunology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pediatric Allergy/Immunology Physician US NPIs
Specialty board-certified rate — Pediatric Allergy/Immunology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK MOSS, MD appears in the CMS NPPES registry as a Pediatric Allergy/Immunology Physician provider holding MD credentials at 600 HIGHLAND AVE, MADISON, WI, 53792, with a listed phone of (608) 263-6180. NPI 1093781163 was issued on 02/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MOSS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 568 prescription claims written by this provider, covering 51 Medicare beneficiaries and totaling roughly $254K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pediatric Allergy/Immunology Physician is a narrow specialty nationwide, with 419 enrolled providers across 43 states and an average of 345 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093781163 |
|---|---|
| Specialty | Pediatric Allergy/Immunology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 02/27/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK MOSS, MD's current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MARK MOSS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK MOSS, MD. Source: openpaymentsdata.cms.gov.
Total received
$99
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Travel and Lodging
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 568 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 872
- Total Day Supply
- 24,100
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $243K
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 56.1 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 78% female / 22% male
- Age Distribution
- <65: 28, 65-74: 17, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK MOSS, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
66 claims
- Trelegy Ellipta
Trelegy Ellipta
37 claims
- Fluticasone Propio…
Fluticasone Propionate
34 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
28 claims
- Ventolin Hfa 26
Ventolin Hfa
26 claims
- Xolair 24
Xolair
24 claims
- Breo Ellipta 20
Breo Ellipta
20 claims
- Flovent Hfa 19
Flovent Hfa
19 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 66 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 37 |
| Fluticasone Propionate | 34 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 28 |
| Ventolin Hfa Albuterol Sulfate | 26 |
| Xolair Omalizumab | 24 |
| Breo Ellipta Fluticasone/Vilanterol | 20 |
| Flovent Hfa Fluticasone Propionate | 19 |
| Azelastine Hcl | 18 |
| Famotidine | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Allergy/Immunology Physician Overview
How MARK MOSS, MD fits within the Pediatric Allergy/Immunology Physician landscape nationally.
MARK MOSS, MD's 568 claims are above the specialty average of 345.
Nearby Pediatric Allergy/Immunology Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as MOSS.
Compare Pediatric Allergy/Immunology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is MARK MOSS, MD's specialty? ▼
How much does MARK MOSS, MD prescribe under Medicare Part D? ▼
Where is MARK MOSS, MD located? ▼
What is MARK MOSS, MD's NPI number? ▼
Does MARK MOSS, MD prescribe more brand-name or generic drugs? ▼
How many Pediatric Allergy/Immunology Physician providers are there in the US? ▼
What drugs does MARK MOSS, MD prescribe most often? ▼
Does MARK MOSS, MD accept Medicare? ▼
How can I verify MARK MOSS, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology